Pursuant to Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, Thyrocare Technologies has informed that a team of Fund Managers and Research Analysts of Malabar Investments would be having a meeting with Dr. A. Velumani, Chainnan, Managing Director & CEO, Anand Velumani, Director of the company’s wholly owned subsidiary, Nueclear Healthcare, Dr. Caesar Sengupta, Vice-President-Operations and Sachin Salvi, General Manager-Finance, at the office by 11.00 AM on Monday, December 17, 2018. There could be last minute change in the timings or in the names of the officers the analysts would be meeting. No un-published Price-Sensitive Information will be shared during the above meeting.
The above information is a part of company’s filings submitted to BSE.
Company Name | CMP |
---|---|
Apollo Hospital Ent. | 7000.00 |
Max Healthcare Inst | 1008.35 |
Narayana Hrudayalay | 1265.30 |
Aster DM Healthcare | 442.70 |
Global Health | 1105.25 |
View more.. |